Elisabeth Stögmann

11PUBLICATIONS
48CO-AUTHORS
Instrumental methods (excl. immunological and bioassay methods)Gene expression (incl. microarray and other genome-wide approaches)Epidemiological modellingGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 12, 2026
Progressive Amyloid-Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier.

|Sep 24, 2026
Unified long-read panel for Parkinson's and repeat expansion disorders.

|Jul 02, 2025
Design of a Mobile App and a Clinical Trial Management System for Cognitive Health and Dementia Risk Reduction: User-Centered Design Approach.

Hannes Hilberger, Bianca Buchgraber-Schnalzer, Simone Huber

|Nov 06, 2024
Amyloid-beta antibody treatment in Alzheimer's disease : An update on recent data and outlook on implementation in clinical routine.

Elisabeth Stögmann, Reinhold Schmidt

|Oct 23, 2024
Monoclonal anti-amyloid antibody treatment: the epidemiological profile of the target patients in Austria and the status of treatment-eligible patients registered at an outpatient memory clinic.

Seungjune Lee, Elisabeth Stögmann

|Jul 05, 2024
Real-world performance of plasma p-tau181 in a heterogeneous memory clinic cohort.

Tandis Parvizi, Raphael Wurm, Theresa König

Pageof 2

Frequent Collaborators

3 joint publications

Raphael Wurm

2 joint publications

Helena Untersteiner

2 joint publications

Tandis Parvizi

2 joint publications

Ellen Gelpi